NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/30/2023
Back to search
Official data from USPTO
THEPHARMANETWORK, LLC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
05/30/2023
Trademark type
Combined
Nice classes
5
Filing date
06/11/2021
Registration date
05/30/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/30/2023
Last transaction
05/30/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
03/10/2000
First use in commerce
03/10/2000
Drawing code
3
Owner type
16
Owner location
Parsippany, NJ
Examiner
RENNIE, GABRIELLE M
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the phrase "THEPHARMANETWORK, LLC" with a brush stroke at the top left corner.
Holders and representatives
Holders
ThePharmaNetwork, LLC
Representatives
Howard Shipley GORDON REES SCULLY MANSUKHANI
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparationsnamely dronabinol capsules
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/30/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/14/2023
PUBO
PUBLISHED FOR OPPOSITION
03/14/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/07/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/01/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/01/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/01/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/02/2022
GNFR
FINAL REFUSAL E-MAILED
08/02/2022
CNFR
FINAL REFUSAL WRITTEN
08/02/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/09/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/08/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/08/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/14/2022
GNRT
NON-FINAL ACTION E-MAILED
02/14/2022
CNRT
NON-FINAL ACTION WRITTEN
02/14/2022
DOCK
ASSIGNED TO EXAMINER
02/09/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/01/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/31/2021
NWAP
NEW APPLICATION ENTERED
06/15/2021
Continuous trademark protection
Get notified about every new filing that threatens THEPHARMANETWORK, LLC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.